| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 19.490 | 38.547 | 47.936 | 53.746 | 70.832 | 104.272 | 106.173 | 116.315 | 151.246 | 119.596 |
| Total Income - EUR | 19.490 | 38.551 | 47.943 | 53.749 | 70.838 | 104.638 | 106.174 | 116.317 | 151.260 | 119.720 |
| Total Expenses - EUR | 6.439 | 11.239 | 11.816 | 19.830 | 19.643 | 15.037 | 17.637 | 24.201 | 36.215 | 41.518 |
| Gross Profit/Loss - EUR | 13.051 | 27.311 | 36.127 | 33.919 | 51.195 | 89.601 | 88.537 | 92.116 | 115.045 | 78.202 |
| Net Profit/Loss - EUR | 12.464 | 26.356 | 35.762 | 33.381 | 50.487 | 88.576 | 87.496 | 90.953 | 113.563 | 67.963 |
| Employees | 0 | 0 | 1 | 2 | 2 | 1 | 1 | 2 | 4 | 3 |
Check the financial reports for the company - Adal Nicolaas Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 697 | 1.246 | 935 | 1.312 | 982 | 1.710 | 1.316 | 963 | 716 | 1.101 |
| Current Assets | 17.733 | 26.302 | 51.914 | 62.055 | 78.960 | 134.392 | 96.639 | 61.661 | 129.037 | 130.232 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 4.717 | 2.903 | 3.553 | 1.939 | 5.927 | 8.329 | 7.538 | 23.888 | 54.125 | 27.938 |
| Cash | 13.017 | 23.399 | 48.361 | 60.116 | 73.033 | 126.063 | 89.101 | 37.773 | 74.912 | 102.295 |
| Shareholders Funds | 13.169 | 26.412 | 51.589 | 62.534 | 78.536 | 132.942 | 87.548 | 52.828 | 113.614 | 100.529 |
| Social Capital | 47 | 47 | 46 | 45 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | 5.261 | 1.135 | 1.260 | 833 | 1.406 | 3.160 | 10.407 | 9.795 | 16.139 | 30.805 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Adal Nicolaas Med Srl